Myelodysplastic Syndrome (MDS) Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Myelodysplastic Syndromes Information Center has current, evidence-based information for you. Get the facts about myelodysplastic syndromes early detection, treatment, and survivorship, and stay up to date with ongoing myelodysplastic syndromes research that could impact your treatment decisions through our daily cancer news.
You are not alone—join us in our safe and private online community for support and inspiration, and share your experience with thousands of other individuals who have been affected by myelodysplastic syndromes cancer. Join the discussion now to share your story and to learn how others like you have dealt with diagnosis, treatment decisions, side effects, living with metastatic disease, caregiving, and survivorship. Login or register here.
People who follow the diet and lifestyle recommendations laid out by the WCRF and the AICR have a 20 percent reduced risk of dying from cancer. Cancer Deaths on the Decline
Overall cancer death rates are declining and cancer incidence has decreased in men and stabilized in women. Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide... Chemotherapy for Older Patients: What You Should Know About the Risk of Infection
As you may already know, chemotherapy works by attacking the rapidly dividing cells...
Myelodysplastic Syndrome Management
Sean Swarner is a master of setting a goal and achieving it. So when he... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Myelodysplastic Syndrome Clinical Trials
ECOGE1905 – A Randomized Phase II Trial of Azacitidine with or without the Histone Deacetylase Inhibitor MS-275 for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (dysplastic type), and Acute Myeloid Leukemia with Multilineage Dysplasia.
DACO-020 – Phase 2 study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Advanced-Stage Myelodysplastic Syndromes
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors